Robert Andrew Douglas - 11 Nov 2022 Form 4 Insider Report for RESMED INC (RMD)

Role
President and COO
Signature
Robert Douglas, President and Chief Operating Officer, ResMed Inc.
Issuer symbol
RMD
Transactions as of
11 Nov 2022
Net transactions value
-$383,932
Form type
4
Filing time
15 Nov 2022, 17:54:53 UTC
Previous filing
17 Oct 2022
Next filing
16 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Tax liability $212,795 -945 -2.7% $225.18 34,194 11 Nov 2022 Direct F1
transaction RMD ResMed Common Stock Tax liability $171,137 -760 -2.2% $225.18 33,434 11 Nov 2022 Direct F2, F3
holding RMD ResMed Common Stock 227,708 11 Nov 2022 Douglas Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2020.
F2 Disposition to issuer for tax withholding on scheduled vesting of Restricted Stock Units granted 11/18/2021.
F3 Includes 52.908 shares of ResMed stock purchased on October 31, 2022, through the ResMed Employee Stock Purchase Plan.